adwivedi@gitam.edu
LinkedIn
Google Scholar
Scopus
ORCiD
Dr. Ashish Ranjan Dwivedi is a distinguished academic in the field of medicinal chemistry, with a focus on the synthesis of small heterocyclic molecules and their evaluation as potential treatments for cancer and neurological disorders. Currently serving as an Assistant Professor at the Gandhi Institute of Technology and Management, Dr. Dwivedi's contributions to the scientific community are reflected in his numerous publications, highlighting his expertise and dedication to research.
Research Publications
- A decade of USFDA-approved small molecules as anti-inflammatory agents: Recent trends and Commentaries on the “industrial” perspective.
- Synthesis and screening of novel 4-N-heterocyclic-2-aryl-6, 7, 8-trimethoxyquinazolines as antiproliferative and tubulin polymerization inhibitors
- Caesium carbonate promoted regioselective O-functionalization of 4, 6-diphenylpyrimidin-2 (1 H)-ones under mild conditions and mechanistic insight
- Iodine-PEG as a unique combination for the metal-free synthesis of flavonoids through iodonium-triiodide ion-pair complexation
- Design, Synthesis, and Pharmacological Evaluation of N-Propargylated Diphenylpyrimidines as Multitarget Directed Ligands for the Treatment of Alzheimer’s Disease
Ongoing Research Projects
-
“Development of Dual Amyloid β Aggregation Modulators and Acetylcholinesterase inhibitors as Neuroprotective Agents for the Treatment of Alzheimer’s Disease.”,
Expertise
-
Design and synthesis of small heterocyclic molecules targeting Cancer and Neurological Disorder
-
Anticancer profiling like cytotoxicity, apoptosis, necrosis of synthesized compounds
Authored Books
-
Clinical trials, regulatory considerations, and market overview of antibiotics
